Medical imaging and radiology
Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directorySkin Analytics DERM medical AI product profile
Class III CE-marked dermatology AI medical device used in UK skin cancer pathways to assess dermoscopic lesion images and support triage.
Medical imaging and radiology
Best fit
Governed dermatology services evaluating AI-enabled teledermatology triage with post-market surveillance and clinician-reviewed pathway design.
- Primary use case
- AI as a medical device for skin lesion assessment, urgent suspected skin cancer triage, and dermatology pathway prioritization
- Audience
- NHS dermatology services, teledermatology pathways, cancer-referral teams, secondary-care providers, and AI governance committees
- Risk level
- High
- Pricing signal
- Health-system and pathway pricing is not public; request current deployment, service, and regional regulatory terms.
- Official sources
- 4 official sources
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Skin Analytics DERM as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify the exact jurisdiction and pathway because CE-marked UK deployment, MHRA oversight, NHS use, and U.S. investigational status create different obligations. |
|---|---|
| Privacy | Review dermatology-image capture, teledermatology routing, identifiers, data protection, ISO 27001, GDPR, NHS DSP Toolkit, DTAC, retention, support access, and patient notice. |
| Evidence | Use post-market surveillance and independent evaluations as starting evidence, then validate local imaging quality, lesion mix, melanoma prevalence, equity, and escalation outcomes. |
| Workflow | Best governed as a pathway-level triage system with explicit image acquisition standards, dermatologist review rules, safety-netting, audit, incident review, and patient communication. |
Where Skin Analytics DERM fits
Skin Analytics states that DERM is a Class III CE-marked AI as a Medical Device for skin cancer, has been deployed across NHS pathways, and publishes post-market performance, certifications, clinical evidence, and information-security materials; its site also notes U.S. investigational-device limitations.
Not for: U.S. commercial clinical use without confirming investigational limits, unsupervised consumer diagnosis, or deployment outside supported imaging and referral pathways.
What to verify before using Skin Analytics DERM
- Class III CE mark, MHRA status, U.S. investigational status, intended pathway, imaging requirements, and whether local use is autonomous triage or clinician-reviewed support.
- How DERM captures, stores, reviews, and routes dermoscopic images, metadata, patient identifiers, reports, and clinician decisions.
- Post-market surveillance evidence, performance by lesion type and skin tone, independent evaluations, false-negative handling, and dermatology escalation rules.
- NHS or local clinical safety case, information governance, ISO certifications, incident reporting, patient communication, and fallback pathways for unassessable lesions.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- skin-analytics.com / ai-pathways / derm-performance
- skin-analytics.com / ai-pathways / certifications
- skin-analytics.com / faq
- skin-analytics.com / privacy-policy
Related medical AI products
Medical imaging and radiology
Viz.ai
AI-powered care coordination platform with imaging-driven alerts across therapeutic areas.
Medical imaging and radiology
Ferrum Health
Clinical AI governance and deployment platform for health systems adopting multiple imaging or clinical AI models.
Medical imaging and radiology
Blackford Platform
Enterprise medical imaging AI platform for evaluating, deploying, routing, and monitoring multiple radiology AI applications.